Membranoproliferative glomerulonephritis complicating Propionibacterium acnes infection

Anja Cornér1, Kati Kaartinen1, Sari Aaltonen1

  • 1Department of Nephrology , Helsinki University Central Hospital , Helsinki , Finland.

Clinical Kidney Journal
|November 8, 2016
PubMed
Abstract

Insights

Propionibacterium acnes (P. acnes) infection can cause membranoproliferative glomerulonephritis (MPGN). Eradicating the P. acnes infection successfully treated both patients, highlighting the importance of infection screening in MPGN cases.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Microbiology

Background:

  • Propionibacterium acnes (P. acnes), a common skin microbe, is rarely considered pathogenic but can cause severe infections.
  • P. acnes infections can lead to chronic low-grade antigenemia, potentially triggering immune-mediated glomerulonephritis.
  • Membranoproliferative glomerulonephritis (MPGN) is one of the renal pathologies associated with P. acnes-induced antigenemia.

Purpose of the Study:

  • To report two cases of P. acnes infection-induced MPGN.
  • To describe the successful treatment of these cases.
  • To emphasize the importance of considering infection in MPGN diagnosis.

Main Methods:

  • Case report of two patients diagnosed with P. acnes infection-induced MPGN.
  • Description of treatment strategies employed for both patients.
  • Review of diagnostic considerations for secondary MPGN.

Main Results:

  • Both patients achieved successful treatment outcomes following the eradication of P. acnes infection.
  • One patient received immunosuppressive therapy before the underlying infection was identified.

Conclusions:

  • Infection screening is crucial in cases of MPGN type I or immune-complex-mediated MPGN.
  • Identifying and treating secondary infections can lead to resolution of MPGN.
  • P. acnes should be considered as a potential trigger for secondary MPGN.

Related Concept Videos

Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
973
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
579
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
578